Comorbidities in unclassifiable interstitial lung disease
Abstract Background Comorbidities are common in interstitial lung diseases (ILD) and have an important association with survival, but the frequency and prognostic impact of comorbidities in unclassifiable interstitial lung disease (uILD) remains elusive. We aimed to describe the prevalence of comorb...
Main Authors: | Thomas Skovhus Prior, Charlotte Hyldgaard, Sebastiano Emanuele Torrisi, Sissel Kronborg-White, Claudia Ganter, Elisabeth Bendstrup, Michael Kreuter |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-03-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12931-022-01981-3 |
Similar Items
-
Clusters of comorbidities in fibrotic hypersensitivity pneumonitis
by: Thomas Skovhus Prior, et al.
Published: (2022-12-01) -
Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a post-hoc Analysis
by: Maria Molina-Molina, et al.
Published: (2022-06-01) -
Palliation of chronic breathlessness with morphine in patients with fibrotic interstitial lung disease – a randomised placebo-controlled trial
by: Sissel Kronborg-White, et al.
Published: (2020-07-01) -
Paclitaxel induced chronic fibrosing interstitial pneumonitis: a case report and review of the literature
by: Renata Ferrarotto, et al.
Published: (2011-12-01) -
Unclassified congenital deformities of the external ear
by: Madhubari Vathulya
Published: (2018-01-01)